PR Newswire

Huma receives multi-condition US FDA 510(k) Class II regulatory clearance for its configurable SaMD disease management platform

Class II clearance expands the patient population that can be managed Companies working with Huma's platform can now launch algorithm innovations more quickly in a compliant and de-risked manner, ...
PR Newswire

Huma has been named Europe's fastest growing healthcare company by the Financial Times and in the Top 25 fastest growing across all sectors

LONDON and NEW YORK, March 11, 2021 /PRNewswire/ -- Huma's exponential growth in healthcare and lifesciences across Europe has been recognised by the Financial Times. Huma is leading healthcare and ...